Use of melatonin for cardiovascular diseases/ Myocardial ischemia-reperfusion injury and melatonin

References (6)

1. Şahna E, Deniz E, Aksulu HE. Miyokardiyal iskemi-reperfüzyon hasarı ve melatonin. Anadolu Kardiyol Derg 2006; 6: 163-8
2. Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 2005; 18: 1614-8
3. Zaslavskaia RM, Biiasilov NS, Akhmetov KZh, Teiblium MM. Capozide-50 alone and in combination with melatonin in therapy of hypertension Klin Med 2000; 78: 39-41
4. Yaprak M, Altun A, Vardar A, Aktoz M, Ciftci S, Özbay G. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 2003; 89: 103-7
5. Altun A, Yaprak M, Aktoz M, Vardar A, Betul UA, Özbay G. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Let. 2002; 327: 143-5
6. Opie LH. The heart physiology from cell to circulation. 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1998.